Technical Articles

BCL-xL/VHL
基于TR-FRET技术的BCL-xL/VHL PROTAC降解剂在抗肿瘤治疗中的研究
Research on BCL-xL/VHL PROTAC Degraders Based on TR-FRET Technology in Antitumor Therapy
发布时间 2026-04-16
BCL-xL is an important anti-apoptotic protein in the BCL-2 family, overexpressed in various cancer cells, and is a well-established therapeutic target for anti-tumor effects.
View details
  • Cancer
  • BCL-xL/VHL
  • Cancer Therapy
  • TR-FRET Technology
Total 1
  • 1
Go to
UA
Link：
Products
Application
Cell FactorTarget Proteins
Custom Services
Custom Protein Expression ServicesCustom SPR Services
About Us
PromotionTechnical ArticlesProduct ApplicationFAQsCitationsAbout Us
We Media：
Facebook Linkedin YouTube X Thraeds Pinterest
©2021-2026 all rights reserved UA Biotechnology Co.,Ltd.
Privacy Policy
网站备案号 浙ICP备2022019033号-2 浙公网安备33010202004867号
 Business license (three certificates in one)
Tel：+86-25-56221161
E-mail：order@ua-bio.com
All products sold on this website shall not be used for clinical diagnosis or treatment of humans or animals, and shall only be used for non-medical purposes such as industrial or scientific research.